TELESTA THERAPEUTICS INC T.TST

Dr. Michael Berendt, noted...

[Biostocks01]

In  parallel,  with  our  board,  investors  and  advisors,  we are carefully analysing  the multiple  strategic options  that  can  best  leverage  our  financial  and  human  resources  to  create  value  for  our  shareholders.    
The current climate of uncertainty in the financial markets has created opportunities for well capitalized companies that were simply not available even a few months ago

How to interpret these words ??

Bio

[tineta]

Sounds like that M & A is coming.

[DamnYankees]

speaking of M & A it be a good time to revisit to poison pill. I'm not the only one noticing that a complete, and largely successful bladder cancer P3 and the FDA pathway for a second ( and more than likely expedited trial) is currently valued at $0.00. 

[calenderj]

This post has been removed in accordance with Community Policy

[somweyungguy]

Impressive paste.... Tell ya Pender Capital Boy...I know the story of the "granite company"...know it well. Ask the doctor if he noted it would be a "special idea" to look at getting a company that had FINISHED ALL PHASE III TRIAL work on to a real US exchange complete with credibility and a following.  In hindsight does BNFLF on the OTC PINK experience scream we